Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T82543 | ||||
Target Name | Neuronal acetylcholine receptor beta-2 (CHRNB2) | ||||
Type of Target |
Clinical trial |
||||
Drug Potency against Target | Sofinicline | Drug Info | EC50 = 40 nM | [7] | |
(2S,3S)-2-(m-Tolyl)-3,5,5-trimethylmorpholin-2-ol | Drug Info | IC50 = 6000 nM | [8] | ||
(2S,3S)-2-Phenyl-3,5,5-trimethylmorpholin-2-ol | Drug Info | IC50 = 6400 nM | [8] | ||
3-[2-(N,N,N-trimethylammonium)ethoxy]pyridine | Drug Info | Ki = 0.5 nM | [3] | ||
4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one | Drug Info | Ki < 1000 nM | [9] | ||
6'-methylepibatidine | Drug Info | Ki = 256 nM | [6] | ||
BOLDINE | Drug Info | Ki = 3000 nM | [5] | ||
CYTISINE | Drug Info | Ki = 2.59 nM | [4] | ||
GCCSHPACAGNNQHIC* | Drug Info | IC50 = 1.1 nM | [1] | ||
GCCSNPVCHLEHSNLC* | Drug Info | IC50 = 8 nM | [1] | ||
HOMOEPIBATIDINE | Drug Info | Ki = 0.127 nM | [4] | ||
N,N-dimethyl(pyridin-3-yl)methanamine | Drug Info | Ki = 540 nM | [2] | ||
N,N-dimethyl-2-(pyridin-3-yloxy)ethanamine | Drug Info | Ki = 21 nM | [2] | ||
N,N-dimethyl-4-(pyridin-3-yl)but-3-yn-1-amine | Drug Info | Ki = 510 nM | [2] | ||
N-ethyl-N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine | Drug Info | Ki = 1770 nM | [2] | ||
N-methyl-2-(pyridin-3-yloxy)ethanamine | Drug Info | Ki = 35 nM | [2] | ||
N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine | Drug Info | Ki = 113 nM | [2] | ||
N-methyl-N-(pyridin-3-ylmethyl)ethanamine | Drug Info | Ki = 28 nM | [2] | ||
Predicentrine methiodide | Drug Info | Ki = 970 nM | [5] | ||
References | |||||
REF 1 | Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem. 2005 Jul 28;48(15):4705-45. | ||||
REF 2 | Synthesis and analgesic activity of secondary amine analogues of pyridylmethylamine and positional isomeric analogues of ABT-594. Bioorg Med Chem Lett. 2006 Apr 1;16(7):2013-6. | ||||
REF 3 | Aryloxyethylamines: binding at alpha7 nicotinic acetylcholine receptors. Bioorg Med Chem Lett. 2006 Aug 15;16(16):4283-6. | ||||
REF 4 | Epibatidine isomers and analogues: structure-activity relationships. Bioorg Med Chem Lett. 2006 Nov 1;16(21):5493-7. | ||||
REF 5 | Aporphine metho salts as neuronal nicotinic acetylcholine receptor blockers. Bioorg Med Chem. 2007 May 15;15(10):3368-72. | ||||
REF 6 | Synthesis and nicotinic acetylcholine receptor binding properties of bridged and fused ring analogues of epibatidine. J Med Chem. 2007 Dec 13;50(25):6383-91. | ||||
REF 7 | In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methy... J Pharmacol Exp Ther. 2009 Jul;330(1):257-67. | ||||
REF 8 | Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation. J Med Chem. 2010 Jun 24;53(12):4731-48. | ||||
REF 9 | Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 rec... J Med Chem. 2010 Sep 9;53(17):6386-97. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.